Donepezil Versus Non-drug Treatment in Alzheimer's Disease. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Donepezil Versus Non-drug Treatment in Alzheimer's Disease. — Stella

Home/Alzheimer Disease, Early Onset/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease, Early Onset trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

France

Cognitive Neurology Center, Paris

Key details

Phase

Large-scale testing

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

France Alzheimer

Enrollment target

~240 participants

Started

February 2022

Primary completion

August 2026

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

50 Years and older

Last updated February 2026